Stock 002727 YIXINTANG PHARMACEUTICAL GROUP CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Yixintang Pharmaceutical Group Co., Ltd.

Equities

002727

CNE100001WJ8

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-07-10 pm EDT 		5-day change 1st Jan Change
13.89 CNY +2.13% Intraday chart for Yixintang Pharmaceutical Group Co., Ltd. -7.58% -40.03%
Jun. 14 Yixintang Pharmaceutical Buys 15 Drugstore Outlets for 20 Million Yuan MT
Jun. 14 Yixintang Pharmaceutical Buys 29 Pharmaceutical Outlets for 16.3 Million Yuan MT

Highlights

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Yixintang Pharmaceutical Buys 15 Drugstore Outlets for 20 Million Yuan
MT
Yixintang Pharmaceutical Buys 29 Pharmaceutical Outlets for 16.3 Million Yuan
MT
Yixintang Pharmaceutical Unit Buys 29 Drug Stores for 16 Million Yuan
MT
Yixintang Pharmaceutical to Hold Internal Probe Over Insurance Fund Misuse
MT
Yixintang Pharmaceutical Group Co., Ltd.'s Board intends to launch an Equity Buyback.
CI
Yixintang Pharmaceutical Group Co., Ltd. Announces Dividend Implementation for 2023, Payable on 30 May 2024
CI
Yixintang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Yixintang Pharmaceutical's Profit Falls 46% as Revenue Stays Nearly Flat
MT
Yixintang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Yixintang Pharmaceutical Group Co., Ltd. completed the acquisition of Assets and Inventories of 10 Stores from Yiliang Yijun Pharmaceutical Co., Ltd.
CI
Yixintang Pharmaceutical Group Co., Ltd. agreed to acquire Assets and Inventories of 10 Stores from Yiliang Yijun Pharmaceutical Co., Ltd. for CNY 8.40 million.
CI
Yixintang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Yixintang Pharmaceutical to Buy 43 Stores From Local Peer For 87 Million Yuan
MT
Yixintang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Yixintang Pharmaceutical Group Co., Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 26 May 2023
CI
Yixintang Pharmaceutical Group Co., Ltd. Approves Cash Dividend for the Year 2022
CI
Yixintang Pharmaceutical Group Co., Ltd. Proposes Cash Dividend for the Year 2022
CI
Yixintang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Yixintang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Yixintang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 002727 Stock
  4. News Yixintang Pharmaceutical Group Co., Ltd.
  5. Highlights